| For: | Jitpraphawan O, Ruamtawee W, Treewatchareekorn M, Sethasine S. Diagnostic and prognostic performances of GALAD score in staging and 1-year mortality of hepatocellular carcinoma: A prospective study. World J Gastroenterol 2024; 30(17): 2343-2353 [PMID: 38813057 DOI: 10.3748/wjg.v30.i17.2343] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v30/i17/2343.htm |
| Number | Citing Articles |
| 1 |
Magdolna Casian, Ioana Manea, Oana Hosu-Stancioiu, María Jesús Lobo Castañón, Noemí de-los-Santos-Álvarez, Cecilia Cristea. Targeting hepatocellular carcinoma with aptamers: from biomarker detection to therapeutic applications. TrAC Trends in Analytical Chemistry 2025; 191: 118346 doi: 10.1016/j.trac.2025.118346
|
| 2 |
Zülal İstemihan, İbrahim Volkan Şenkal, Dilan Karaca, Kanan Nuriyev, Aynura Rustamzade, Sezen Genç Uluçeçen, Gizem Dağcı, Mehmet Akif Yağlı, Asım Gurbanov, Pelin Telli, Bilger Çavuş, Aslı Çifcibaşı Örmeci, Filiz Akyüz, Kadir Demir, Fatih Beşışık, Sabahattin Kaymakoğlu. The role of GALAD score in the surveillance of hepatocellular carcinoma. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-07765-1
|
| 3 |
Maher Hendi, Bin Zhang, Jie-Min Lv, Xiu-Jun Cai. Factors influencing anxiety and depression in advanced hepatocellular carcinoma patients and their impact on quality of life. World Journal of Psychiatry 2025; 15(5): 104995 doi: 10.5498/wjp.v15.i5.104995
Abstract(258) |
Core Tip(318) |
Full Article(HTML)(1275)
|
Full Article with Cover (PDF)-4765K(105)
|
Audio-2186K(4)
|
Peer-Review Report-195K(54)
|
Answering Reviewers-42K(55)
|
Supplementary Material-235K(51)
|
Full Article (PDF)-1026K(81)
|
Full Article (XML)-128K(53)
|
Times Cited (0)
|
Total Visits (3696)
|
Open
|
| 4 |
Yuto Shiode, Takahiro Kodama, Yu Sato, Ryo Takahashi, Takayuki Matsumae, Kumiko Shirai, Akira Doi, Yuki Tahata, Hayato Hikita, Tomohide Tatsumi, Moto Fukai, Akinobu Taketomi, Mathuros Ruchirawat, Xin Wei Wang, Tetsuo Takehara. Folate receptor 1 is a stemness trait-associated diagnostic and prognostic marker for hepatocellular carcinoma. Biomarker Research 2025; 13(1) doi: 10.1186/s40364-025-00752-8
|
| 5 |
Coskun Ozer Demirtas, Fatih Eren, Demet Yilmaz Karadag, Yasemin Kaldirim Armutcuoglu, Tugba Tolu, Javid Huseyinov, Ugur Ciftci, Tuba Yilmaz, Sehnaz Akin, Feyza Dilber, Osman Cavit Ozdogan. BALAD-2 Emerges as the Most Accurate Prognostic Model in Hepatocellular Carcinoma: Results from a Biobank-Based Cohort Study. Cancers 2025; 17(21): 3457 doi: 10.3390/cancers17213457
|
